DSS Secures Nine Patents for Digital Prism Anti-Scanning Technology

Document Security Systems, Inc. (NYSE Amex: DMC; "DSS"), a world leader in the development and manufacturing of products and packaging containing optical deterrent and authentication technologies that help prevent counterfeiting and brand fraud from the use of desktop scanners and copiers, is pleased to announce today that it has been issued nine new patents covering seven European Countries and Canada.

All patents are associated with DSS's new digital "Prism" authentication and anti-counterfeiting technology which was recently highlighted as a "Covert security technology for plastic smart cards" on page 39 of a comprehensive industry white paper by Imperial Capital entitled, "Anti-Counterfeiting & Brand Protection.

In addition to "Smart Cards," Prism also can protect labels, packaging, documents, currency and vital records.

Michael Caton, Chief Technology Officer of Document Security Systems, Inc., stated, "Based on our testing, Prism technology is the most powerful anti-scanning technology on the market.  That's important because according to the U.S. Secret Service, scanning is the most prevalent method used by counterfeiters.  Prism has never been captured by any scanning device regardless of the resolution which makes it 100% effective as an inexpensive authentication technology for all brand owners. The technology is inexpensive since it is easily applied in the traditional or digital print production process and it does not require expensive, slow, hardware and software add-ons like competitors are offering."

Patrick White, CEO, stated, "I am really proud of the innovation of our engineers and our legal team at Harter Secrest & Emery LLP for their excellent work on our valuable and growing intellectual property portfolio."

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.